Jessica J Lin
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Jessica J Lin
Sep 24, 2024, 13:32 |
Insight
Jarushka Naidoo: Stage III ALK+ NSCLC - consolidation ALK TKI vs Durvalumab vs Observation
Jarushka Naidoo shared on X: "Stage III ALK+ NSCLC: consolidation ALK Tyrosine Kinase Inhibitors versus…
Sep 19, 2024, 09:23 |
Insight
Jessica Lin: Preclinical development and proof-of-concept clinical activity of NVL-655
Jessica Lin shared a post on LinkedIn: "We are pleased to share this article out today…
Sep 14, 2024, 06:41 |
Societies
Best of WCLC24
The WCLC24 took place at the San Diego Convention Center from September 7 to 10,…
Sep 10, 2024, 05:38 |
Blog
WCLC24 Social Media Ambassadors
Narjust Florez shared a post on X: "Our social media ambassadors for WCLC24. Make sure…
Jul 4, 2024, 03:53 |
Blog
Sarah Waliany: Reviewing the TRUST-1 trial investigating taletrectinib
Sarah Waliany, Thoracic Oncology Fellow at Mass General Cancer Center, shared the following post by…
Feb 7, 2024, 12:46 |
Blog
Amin Nassar presents the results of a multicenter retrospective cohort for osimertinib and durvalumab in unresectable EGFR-mutant NSCLC
Amin Nassar, Hematology/Oncology Fellow at Yale University, shared a post on X/Twitter: "1. Pumped to…
All:
6
Posts:
1 - 100
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Gavin Creel: Broadway Icon Dies After Battle with Rare Sarcoma at 48
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube